Drug Topics

MARCH 28, 2025

Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.

FDA 412

FDA 412

STAT

MARCH 28, 2025

Food programs in poor neighborhoods. People to track surges of Covid, measles, or other diseases. Programs to help people with addiction. The cascade of budget cuts from Washington has hundreds of state and local health officials around the country struggling to assess the impact on their communities and departments.

128

128

Drug Topics

MARCH 28, 2025

Currently, there is no vaccine to prevent chlamydia, but treatment includes regimens of antibiotics, including doxycycline, azithromycin, and levofloxacin.

Vaccines 283

Vaccines FDA 283

STAT

MARCH 28, 2025

WASHINGTON — Keith Joung knows better than a lot of people what, exactly, it might require to prove to regulators and patients that CRISPR could be safely used to alter the genome of a human embryo. If, of course, society decided that was a good idea. Joung, an early pioneer of the gene-editing technology, was the first to show CRISPR could target and cut DNA inside an embryo — in zebrafish — back in 2013.

131

131

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MARCH 28, 2025

Lauren Angelo, PharmD, associate dean for academic affairs at Rosalind Franklin University, explains common misconceptions and myths about vaccines.

Vaccines 247

Vaccines 247

STAT

MARCH 28, 2025

In a blow to the pharmaceutical industry, a U.S. court judge ruled that a Colorado state board can proceed with plans to place limits on the prices paid for medicines, the first such decision to support the controversial attempts by some states to control their prescription drug spending. The case had been filed last year by Amgen after the state Prescription Drug Affordability Board determined that its big-selling medication called Enbrel is unaffordable and began a process to create a so-calle

112

112

PharmaVoice

MARCH 28, 2025

The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and leaning toward good science.

147

147

Pharmafile

MARCH 28, 2025

The US Food and Drug Association (FDA) has granted fast track designation to Sanofis mRNA vaccine candidate for the prevention of chlamydia infection. The chlamydia vaccine candidate has been designed to protect against primary genital tract infection and reinfection caused by the bacterium Chlamydia trachomatis. Sanofi is an international pharma and healthcare company, providing vaccination […] The post FDA grants fast track designation to chlamydia vaccine candidate appeared first on Pha

Vaccines 69

Vaccines FDA 69

Pharma Marketing Network

MARCH 28, 2025

Introduction Weekends may be synonymous with relaxation, but for pharma marketing professionals, they offer an unmatched window to recalibrate. When deadlines arent looming and inboxes arent overflowing, theres finally time to revisit trends, read strategy insights, and uncover tools to elevate your marketing game. The Pharma Marketing Network serves as an ideal destination for this kind of weekend deep-dive.

FDA 59

FDA 59

Pharmacy Times

MARCH 28, 2025

Greg Clyde, PharmD, shares his love of pharmacy with patients in oklahoma.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

MARCH 28, 2025

The global pharmaceutical & biotechnology environmental monitoring market is expected to expand with a CAGR of 6.2 percent between 2025 and 2031, according a report by Lucintel. Several factors are fuelling this growth, including greater adoption of advanced innovations such as cloud technology, which are driving efficiencies and accuracy, the research highlighted.

59

59

Pharmacy Times

MARCH 28, 2025

Approval of durvalumab is in combination with gemcitabine and cisplatin as neoadjuvant treatment for adults with muscle invasive bladder cancer.

FDA 122

FDA 122

European Pharmaceutical Review

MARCH 28, 2025

Artificial intelligence (AI) and Big Data are set to remain the most disruptive powers in the healthcare sector for the next two years, with Pharma executives prioritizing these innovations for the near future, according to GlobalData. 1 This report delves into some of the major obstacles and the potential for AI in the pharmaceutical industry. Register now to access exclusive content and insight from: Dr Vladimir Makarov, Programme Manager, The Pistoia Alliance Remco Jan Geukes Foppen, Vincenzo

59

59

Fierce Healthcare

MARCH 28, 2025

The healthcare industry must shift from thinking you are lucky to be able to see us, to we are so fortunate to have the privilege to care for you.

105

105

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MARCH 28, 2025

Pharmacy Times will be on-site in Chicago, Illinois from March 29 through 31.

93

93

pharmaphorum

MARCH 28, 2025

Eli Lilly's DTC platform LillyDirect has been expanded to include in-person and telehealth services for people in the US living with Alzheimer's

72

72

Pharmacy Times

MARCH 28, 2025

In certain patients with chronic kidney disease (CKD), peritoneal dialysis maintained hemodynamic stability, optimal nutritional status, reduced hospitalization, and lowered diuretics reliance.

Hospitals 90

Hospitals 90

Fierce Healthcare

MARCH 28, 2025

Legislation reintroduced this week would have Medicare plans' prior authorization decisions and policies made by board-certified specialist physicians. Its sponsors and proponents say it would streamline needed care and reduce administrative burden.

72

72

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MARCH 28, 2025

Marc Bonaca, MD, PHH, FACC discussed semaglutides potential benefits for non-diabetic patients with peripheral artery disease.

81

81

pharmaphorum

MARCH 28, 2025

Fast-growing pharma group Chiesi has revealed plans to spend 430m on a new therapeutics manufacturing facility at its site in Milan

72

72

STAT

MARCH 28, 2025

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

65

65

Fierce Healthcare

MARCH 28, 2025

Here's your health tech roundup: Athenahealth survey of community practitioner finds improved perception of AI; Sentara taps Inflo Health for missed radiology follow ups; New EHR launches for behavioral health providers.

65

65

Pharmacy Times

MARCH 28, 2025

Colorectal cancer cases are on the risehere is everything you need to know as an oncology pharmacist.

65

65

Fierce Healthcare

MARCH 28, 2025

Omada Health is joining forces with CVS Health's Caremark as part of the pharmacy benefit manager's weight management program. | Omada Health is joining forces with CVS Health's Caremark as part of the pharmacy benefit manager's weight management program.

59

59

Pharmacy Times

MARCH 28, 2025

Vitamin E intake, specifically -tocopherol, may reduce the development of peanut allergies and anaphylaxis in newborns.

65

65

pharmaphorum

MARCH 28, 2025

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial

59

59

Pharmacy Times

MARCH 28, 2025

The expanded discount program offers semaglutide for $499 per month for all eligible cash-paying customers.

65

65

Pharmafile

MARCH 28, 2025

Ellab has announced that it has appointed Gergely Sved as its new chief executive officer (CEO). The company provides validation, monitoring and calibration products and services to the life sciences industry. Sved will formally join the company in June, with chief financial officer Andreas Morthorst acting as interim CEO. Sved is a healthcare and life […] The post Gergely Sved appointed as CEO of Ellab appeared first on Pharmafile.

59

59

Pharmacy Times

MARCH 28, 2025

Approval of fitusiran, a small interfering RNA drug, was found effective in patients with hemophilia regardless of inhibitor status.

FDA 65

FDA 65

Pharmafile

MARCH 28, 2025

Asgard Therapeutics has announced the appointment of Shane Olwill as chief development officer (CDO). The biotech company develops in vivo direct cell reprogramming for cancer immunology. Olwill specialises in immunology drug development. In his new position, he will lead Investigational New Drug (IND)-enabling studies and clinical trials planning for Asgards AT-108 therapy.

59

59

Pharmacy Times

MARCH 28, 2025

Kaite Krell, MPH, discusses the critical role of independent pharmacies and how proposed legislation could address challenges with PBMs.

Independent Pharmacies 65

Independent Pharmacies 65

Pharmafile

MARCH 28, 2025

Vect-Horus has announced it has appointed Carole Imbert as chief financial officer (CFO) and to its executive committee. Vect-Horus is a biotechnology company that designs and develops molecular vectors allowing targeted delivery of therapeutic molecules and imaging agents to organs. Imbert specialises in financial management and structuring. She previously served as head of financial and […] The post Carole Imbert appointed as CFO of Vect-Horus appeared first on Pharmafile.

59

59

Pharmacy Times

MARCH 28, 2025

These results align with those from shorter-term analyses of low-density lipoprotein cholesterol (LDL-C) reductions with evolocumab and cognitive impairment risk.

65

65